These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32739601)

  • 21. Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.
    Taylor JL; Bishop C; Ullrich T; Rice KC; Walker PD
    Neuropharmacology; 2006 May; 50(6):761-8. PubMed ID: 16434065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
    Carli M; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):357-63. PubMed ID: 11259563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
    Gehrke BJ; Harrod SB; Cass WA; Bardo MT
    Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a 5-HT
    Shahidi S; Komaki A; Sadeghian R; Soleimani Asl S
    Brain Res; 2018 Nov; 1698():151-160. PubMed ID: 30076792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL; Wang RY
    Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
    Bayat AH; Haghparast A
    Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
    Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the GluN2B-selective antagonist Ro 63-1908 on acquisition and expression of methamphetamine conditioned place preference in male and female rats.
    Yates JR; Campbell HL; Hawley LL; Horchar MJ; Kappesser JL; Wright MR
    Drug Alcohol Depend; 2021 Aug; 225():108785. PubMed ID: 34052688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
    Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
    Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.
    Philogene-Khalid HL; Hicks C; Reitz AB; Liu-Chen LY; Rawls SM
    Drug Alcohol Depend; 2017 Sep; 178():119-125. PubMed ID: 28646714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
    Ardayfio PA; Benvenga MJ; Chaney SF; Love PL; Catlow J; Swanson SP; Marek GJ
    J Pharmacol Exp Ther; 2008 Dec; 327(3):891-7. PubMed ID: 18772320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
    Steed E; Jones CA; McCreary AC
    Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference.
    Herrold AA; Shen F; Graham MP; Harper LK; Specio SE; Tedford CE; Napier TC
    Drug Alcohol Depend; 2009 Jan; 99(1-3):231-9. PubMed ID: 18945553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orphanin FQ/nociceptin blocks methamphetamine place preference in rats.
    Zhao RJ; Woo RS; Jeong MS; Shin BS; Kim DG; Kim KW
    Neuroreport; 2003 Dec; 14(18):2383-5. PubMed ID: 14663196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.